Valion Bio Financials - Benzinga

Valion Bio Inc

VBIONASDAQ

Trade with Public

Trade with Public

$3.31

-0.26-7.28%

Dern. MÀJ: Sep 1, 9:21 AM

Fractionnement d'actions: Valion Bio Inc s'est récemment scindé Monday, August 31, 2026 avec un ratio de 1:25

Aperçu Actualités Prévisions de résultatsDonnées financièresSentiment Actionnariat Comparer Rapport sur les stocks

Valion Bio Financials

Valion Bio (VBIO) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Valion Bio Q1 EPS $(2.23) Up From $(2.52) YoY

Valion Bio (NASDAQ:VBIO) reported quarterly losses of $(2.23) per share. This is a 11.51 percent increase over losses of $(2.52) per share from the same period last year.

Benzinga Newsdesk

Earnings Scheduled For May 14, 2026

Benzinga Insights

© 2026 Benzinga | All Rights Reserved